Christine Sedlik
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies.
Journal: Frontiers in immunology
Published: October 22, 2025
Targeting CD39 in combination with IL-2/anti-IL-2 complexes enhances cytotoxic immunity and limits tumor progression.
Journal: Frontiers in immunology
Published: October 22, 2025
Simple, Rapid, Reproducible and Biomarker-Validated Clinical Grading System for Murine Models of Xenogeneic Graft-Versus-Host Disease.
Journal: Transplantation and cellular therapy
Published: December 23, 2024
Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Journal: EMBO molecular medicine
Published: September 16, 2024
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip.
Journal: Cell reports. Medicine
Published: October 28, 2023
CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity.
Journal: EMBO molecular medicine
Published: April 26, 2023
CD74 supports accumulation and function of regulatory T cells in tumors.
Journal: Nature communications
Published: March 28, 2023
Selective STING stimulation in dendritic cells primes antitumor T cell responses.
Journal: Science immunology
Published: January 13, 2023
Treg-targeted IL-2/anti-IL-2 complex controls graft-versus-host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation.
Journal: Haematologica
Published: January 06, 2023
Last Updated: 09/26/2026